Article

siRNA treatment targeting integrin α11 overexpressed via EZH2- driven axis inhibits drug-resistant breast cancer progression

2024-02-21

Abstract excerpt

<title>Abstract</title> Background Breast cancer, the most prevalent cancer in women worldwide, faces treatment challenges due to drug resistance, posing a serious threat to patient survival. The present study aimed to identify the key molecules that drive drug resistance and aggressiveness in breast cancer cells and validate them as therapeutic targets. Methods Transcriptome microarray and analysis using PA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e8a7312b-520e-5513-acb1-74a7c81f355c
DOI: 10.21203/rs.3.rs-3959945/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

siRNA treatment targeting integrin α11 overexpressed via EZH2- driven axis inhibits drug-resistant breast cancer progressionDOI 10.21203/rs.3.rs-3959945/v1Read

Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancerSemantic proximity Read

Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical ImplicationsSemantic proximity Read

Integrins regulate stemness in solid tumor: an emerging therapeutic target.Semantic proximity Read

Integrins Within the Tumor Microenvironment: Biological Functions and Advances in Therapeutic Targeting Semantic proximity Read

miR-489 Confines Uncontrolled Estrogen Signaling Through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast CancerSemantic proximity Read

Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancerSemantic proximity Read

HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and ProgressionSemantic proximity Read

Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells May be Induced by Interactions Between Receptor Tyrosine Kinases and ERα-66.Semantic proximity Read

β 1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGFβ–miR-200–ZEB Network in E-Cadherin–Positive Triple-Negative Breast CancerSemantic proximity Read

EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin SignalingSemantic proximity Read

ZEB2 Regulates Endocrine Therapy Sensitivity and Metastasis in Luminal A Breast Cancer Through a Non-Canonical MechanismSemantic proximity Read

Chemotherapy-induced tumor gene expression changes in human breast cancersSemantic proximity Read